A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered Cancer
Clinical trial NCT05904457 · UNKNOWN
Trial details
- NCT number
- NCT05904457
- Sponsor
- Asan Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-02
- Primary completion
- 2025-01-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.